A self‐amplifying antimicrobial nanoagent: ALASe combines dark toxicity with in situ porphyrin biosynthesis for enhanced antimicrobial photodynamic therapy

Abstract The rise of multidrug‐resistant bacteria demands innovative antimicrobial strategies that combine multiple mechanisms of action. Selenium nanoparticles functionalized with 5‐aminolevulinic acid (ALASe) offer a dual‐action platform, coupling the intrinsic bactericidal activity of selenium with photodynamic toxicity derived from metabolically generated porphyrins. ALASe nanoparticles were synthesized via a one‐pot photoreduction method and characterized by TEM, DLS, XRD, FTIR, 1 H NMR, HRMS, ICP‐OES, and fluorescence spectroscopy. The resulting nanoparticles were spherical, 180–220 nm in size, with moderate colloidal stability (zeta potential ≈ −26 mV) and fluorescence emission at 514 nm. Antibacterial activity was evaluated against Escherichia coli and Staphylococcus aureus under dark and blue‐light (460 nm) conditions. ALASe exhibited dose‐dependent dark toxicity against both strains, confirming an intrinsic selenium‐mediated antibacterial effect. Upon blue‐light irradiation, bacterial inactivation was significantly enhanced, consistent with metabolic conversion of ALA into photoactive porphyrins. Intracellular porphyrin accumulation was confirmed by fluorescence spectroscopy, and photodynamic efficacy correlated directly with porphyrin levels. Singlet oxygen generation was further quantified by phosphorescence decay analysis of porphyrins extracted from ALASe‐incubated bacteria, confirming the photosensitizing role of the accumulated porphyrins. Together, these results demonstrate that ALASe combines two complementary antibacterial mechanisms: selenium‐dependent dark toxicity and a light‐activatable photodynamic response driven by bacterial conversion of ALA to porphyrin. This dual‐mechanism positions ALASe as a promising multifunctional nanoplatform for combating antibiotic‐resistant infections, particularly in superficial or topical applications where light delivery is feasible.

Authors

Institutions

Publication Details

Journal
Photochemistry and Photobiology
Published
2026-11-14
DOI
https://doi.org/10.1111/php.70167
Primary Topic
Photodynamic Therapy Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A self‐amplifying antimicrobial nanoagent: ALASe combines dark toxicity with in situ porphyrin biosynthesis for enhanced antimicrobial photodynamic therapy

Márcia Regina Franzolin, Susana de Souza Barreto, Jullio Kennedy Castro Soares, Lilia Coronato Courrol et al.
Photochemistry and Photobiology
Photodynamic Therapy Research Studies
article

A self‐amplifying antimicrobial nanoagent: ALASe combines dark toxicity with in situ porphyrin biosynthesis for enhanced antimicrobial photodynamic therapy

Márcia Regina Franzolin, Susana de Souza Barreto, Jullio Kennedy Castro Soares, Lilia Coronato Courrol, Isabela Santos Lopes, Helena C. Junqueira, Divinomar Severino, Christophe Couteau, Kazi Tani Ahmed Charef
article en

Abstract

Abstract The rise of multidrug‐resistant bacteria demands innovative antimicrobial strategies that combine multiple mechanisms of action. Selenium nanoparticles functionalized with 5‐aminolevulinic acid (ALASe) offer a dual‐action platform, coupling the intrinsic bactericidal activity of selenium with photodynamic toxicity derived from metabolically generated porphyrins. ALASe nanoparticles were synthesized via a one‐pot photoreduction method and characterized by TEM, DLS, XRD, FTIR, 1 H NMR, HRMS, ICP‐OES, and fluorescence spectroscopy. The resulting nanoparticles were spherical, 180–220 nm in size, with moderate colloidal stability (zeta potential ≈ −26 mV) and fluorescence emission at 514 nm. Antibacterial activity was evaluated against Escherichia coli and Staphylococcus aureus under dark and blue‐light (460 nm) conditions. ALASe exhibited dose‐dependent dark toxicity against both strains, confirming an intrinsic selenium‐mediated antibacterial effect. Upon blue‐light irradiation, bacterial inactivation was significantly enhanced, consistent with metabolic conversion of ALA into photoactive porphyrins. Intracellular porphyrin accumulation was confirmed by fluorescence spectroscopy, and photodynamic efficacy correlated directly with porphyrin levels. Singlet oxygen generation was further quantified by phosphorescence decay analysis of porphyrins extracted from ALASe‐incubated bacteria, confirming the photosensitizing role of the accumulated porphyrins. Together, these results demonstrate that ALASe combines two complementary antibacterial mechanisms: selenium‐dependent dark toxicity and a light‐activatable photodynamic response driven by bacterial conversion of ALA to porphyrin. This dual‐mechanism positions ALASe as a promising multifunctional nanoplatform for combating antibiotic‐resistant infections, particularly in superficial or topical applications where light delivery is feasible.

Photochemistry and Photobiology
Centre National de la Recherche Scientifique (FR), Université de Technologie de Troyes (FR), Instituto Butantan (BR), Light, nanomaterials, nanotechnologies (FR), Instituto de Ciências Ambientais, Químicas e Farmacêuticas (BR), Universidade Federal de São Paulo (BR)
Photodynamic Therapy Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon